Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Cuzick

Showing results (301-310 of 367) with videos related to

Pageof 37
Sort By:
Cancer Control : Journal of the Moffitt Cancer Center|July 4, 2026
Improving Breast Cancer Outcomes by Enhanced Activities in Early Detection and Diagnosis: An Umbrella Review and Meta-Analyses of Randomised Controlled Trials in High-Income Contexts With Universal Healthcare CoverageKristoffer Halvorsrud, Helen Fowler, Wasim Hamad, et al.
BMJ (Clinical Research Ed.)|May 23, 2007
Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trialGuglielmo Ronco, Jack Cuzick, Paola Pierotti, et al.
JAMA Network Open|November 21, 2019
Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus-Based Screening in MexicoLeticia Torres-Ibarra, Jack Cuzick, Attila T Lorincz, et al.
European Journal of Cancer (Oxford, England : 1990)|January 16, 2007
HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytologyGuglielmo Ronco, Jack Cuzick, Nereo Segnan, et al.
Cancer Cytopathology|July 22, 2014
The low risk of precancer after a screening result of human papillomavirus-negative/atypical squamous cells of undetermined significance papanicolaou and implications for clinical managementJulia C Gage, Hormuzd A Katki, Mark Schiffman, et al.
Journal of the National Cancer Institute|March 28, 2008
Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening testGuglielmo Ronco, Paolo Giorgi-Rossi, Francesca Carozzi, et al.
JAMA Neurology|March 7, 2022
Assessment of Risk Factors and Early Presentations of Parkinson Disease in Primary Care in a Diverse UK PopulationCristina Simonet, Jonathan Bestwick, Mark Jitlal, et al.
Clinical Epigenetics|October 14, 2019
Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16/18 genotypingRubí Hernández-López, Attila T Lorincz, Leticia Torres-Ibarra, et al.
JMIR Formative Research|January 27, 2019
The iPrevent Online Breast Cancer Risk Assessment and Risk Management Tool: Usability and Acceptability TestingLouisa L Lo, Ian M Collins, Mathias Bressel, et al.
Lancet (London, England)|May 4, 2013
Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant dataJack Cuzick, Ivana Sestak, Bernardo Bonanni, et al.
Pageof 37

Showing results (301-310 of 367) with videos related to

Sort By:
Pageof 37
Cancer Control : Journal of the Moffitt Cancer Center|July 4, 2026
Improving Breast Cancer Outcomes by Enhanced Activities in Early Detection and Diagnosis: An Umbrella Review and Meta-Analyses of Randomised Controlled Trials in High-Income Contexts With Universal Healthcare CoverageKristoffer Halvorsrud, Helen Fowler, Wasim Hamad, et al.
BMJ (Clinical Research Ed.)|May 23, 2007
Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trialGuglielmo Ronco, Jack Cuzick, Paola Pierotti, et al.
JAMA Network Open|November 21, 2019
Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus-Based Screening in MexicoLeticia Torres-Ibarra, Jack Cuzick, Attila T Lorincz, et al.
European Journal of Cancer (Oxford, England : 1990)|January 16, 2007
HPV triage for low grade (L-SIL) cytology is appropriate for women over 35 in mass cervical cancer screening using liquid based cytologyGuglielmo Ronco, Jack Cuzick, Nereo Segnan, et al.
Cancer Cytopathology|July 22, 2014
The low risk of precancer after a screening result of human papillomavirus-negative/atypical squamous cells of undetermined significance papanicolaou and implications for clinical managementJulia C Gage, Hormuzd A Katki, Mark Schiffman, et al.
Journal of the National Cancer Institute|March 28, 2008
Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening testGuglielmo Ronco, Paolo Giorgi-Rossi, Francesca Carozzi, et al.
JAMA Neurology|March 7, 2022
Assessment of Risk Factors and Early Presentations of Parkinson Disease in Primary Care in a Diverse UK PopulationCristina Simonet, Jonathan Bestwick, Mark Jitlal, et al.
Clinical Epigenetics|October 14, 2019
Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16/18 genotypingRubí Hernández-López, Attila T Lorincz, Leticia Torres-Ibarra, et al.
JMIR Formative Research|January 27, 2019
The iPrevent Online Breast Cancer Risk Assessment and Risk Management Tool: Usability and Acceptability TestingLouisa L Lo, Ian M Collins, Mathias Bressel, et al.
Lancet (London, England)|May 4, 2013
Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant dataJack Cuzick, Ivana Sestak, Bernardo Bonanni, et al.
Pageof 37